~~<i id='7151691222'><strike id='7151691222'><tt id='7151691222'><pre id='7151691222'></pre></tt></strike></i>~~

Home» explore» leisure time

leisure time

author：explore 2025-10-01 06:06:35 Page View：3419

Neumora, a neuroscience startup founded by VC Arch Venture Partners, hopes to become one of the few biotechs to go public this year.

The company filed paperwork for an IPO with the Securities and Exchange Commission on Friday. It did not state how many shares it plans to sell or at what price.

The biotech had begun planning for an IPO last year, STAT reported in June 2022. It raised $112 million in what would turn out to be a crossover round last October.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank
Next article： Apple is now the first public company to be valued at $3 trillion

Wikipedia

Alkermes shareholders re

MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

Study: Why relieving medical debt did not improve financial outcomes

AdobePhilanthropistsandfoundationsliketheoneIworkfortakealotofcalculatedrisks.Weinvestinresearch,adv

What does generative AI mean for health care? We asked experts

MikeReddyforSTATHealthcarecompaniesareracingtoincorporategenerativeAItoolsintotheirproductpipelinesa

NIH tests clinical research in primary care with $30 million program

TheNIH'snewprimarycareresearchnetworkaimstoimproverepresentationinclinicalscience.AdobeFormanyAmeric